Evidence map›Paper›PMID 30518847›Full record

ReviewNature structural & molecular biology2018

Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay.

Jeffrey S Mugridge, Jeff Coller, John D Gross

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature structural & molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. RNA exoribonucleases in E. coli.Archives of microbiology · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Advances and Strategies in Enhancing mRNA Cancer Vaccines.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  14. Article
  15. Uridine as a hub in cancer metabolism and RNA biology.Experimental & molecular medicine · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jeffrey S MugridgeDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Jeff CollerThe Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-5662-8110
John D GrossDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. jdgross@cgl.ucsf.edu.ORCID http://orcid.org/0000-0002-1377-4705

Funding

Understanding the interconnection between mRNA turnover and mRNA translationR01GM080465 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI COLLER, JEFFERY · 2007 to 2016
$2.7M
Understanding the Interconnection Between mRNA turnover and mRNA TranslationR01GM125086 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLLER, JEFFERY · 2017 to 2020
$1.6M
NIGMS NIH HHS R01 GM080465
6 · The paper itself

Abstract

5'-3' RNA decay pathways are critical for quality control and regulation of gene expression. Structural and biochemical studies have provided insights into the key nucleases that carry out deadenylation, decapping, and exonucleolysis during 5'-3' decay, but detailed understanding of how these activities are coordinated is only beginning to emerge. Here we review recent mechanistic insights into the control of 5'-3' RNA decay, including coupling between translation and decay, coordination between the complexes and activities that process 5' and 3' RNA termini, conformational control of enzymatic activity, liquid phase separation, and RNA modifications.

Indexed as

RNA StabilityGene Expression RegulationModels, MolecularRNA, MessengerRNA, Messenger

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.